- Home
- ATNM vs MPU Comparison
ATNM vs MPU Comparison
Compare ATNM & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MPU
- Stock Information
- Founded
- ATNM 2000
- MPU 1989
- Country
- ATNM United States
- MPU Singapore
- Employees
- ATNM N/A
- MPU N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MPU Transportation Services
- Sector
- ATNM Health Care
- MPU Consumer Discretionary
- Exchange
- ATNM Nasdaq
- MPU Nasdaq
- Market Cap
- ATNM 51.5M
- MPU 40.0M
- IPO Year
- ATNM N/A
- MPU 1998
- Fundamental
- Price
- ATNM $1.54
- MPU $0.95
- Analyst Decision
- ATNM Strong Buy
- MPU
- Analyst Count
- ATNM 3
- MPU 0
- Target Price
- ATNM $4.67
- MPU N/A
- AVG Volume (30 Days)
- ATNM 229.8K
- MPU 226.0K
- Earning Date
- ATNM 05-09-2025
- MPU 06-10-2025
- Dividend Yield
- ATNM N/A
- MPU N/A
- EPS Growth
- ATNM N/A
- MPU N/A
- EPS
- ATNM N/A
- MPU N/A
- Revenue
- ATNM N/A
- MPU $36,184,000.00
- Revenue This Year
- ATNM N/A
- MPU N/A
- Revenue Next Year
- ATNM N/A
- MPU N/A
- P/E Ratio
- ATNM N/A
- MPU N/A
- Revenue Growth
- ATNM N/A
- MPU N/A
- 52 Week Low
- ATNM $1.03
- MPU $0.49
- 52 Week High
- ATNM $8.64
- MPU $1.98
- Technical
- Relative Strength Index (RSI)
- ATNM 49.81
- MPU 55.32
- Support Level
- ATNM $1.56
- MPU $0.80
- Resistance Level
- ATNM $1.69
- MPU $0.97
- Average True Range (ATR)
- ATNM 0.11
- MPU 0.09
- MACD
- ATNM -0.01
- MPU -0.00
- Stochastic Oscillator
- ATNM 32.18
- MPU 59.03
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.